-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ja/f+v5moXyJQpLX7lVUAOB7IoKx8ohgfdFt1sAjhEjr67WC8ahV19479UVHN3ii TQwfPXCl/Oob8PnNDK4wgA== 0001332933-05-000001.txt : 20050718 0001332933-05-000001.hdr.sgml : 20050718 20050718173521 ACCESSION NUMBER: 0001332933-05-000001 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050711 FILED AS OF DATE: 20050718 DATE AS OF CHANGE: 20050718 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 CHIPETA WAY STE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108-1256 BUSINESS PHONE: 8015834939 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Melrose Glenn R CENTRAL INDEX KEY: 0001332933 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 05960190 BUSINESS ADDRESS: BUSINESS PHONE: 801-583-4939 MAIL ADDRESS: STREET 1: 383 COLOROW DRIVE CITY: SALT LAKE CITY STATE: UT ZIP: 84108 3 1 edgar.xml PRIMARY DOCUMENT X0202 3 2005-07-11 1 0000890465 NPS PHARMACEUTICALS INC NPSP 0001332933 Melrose Glenn R 383 COLOROW DRIVE SALT LAKE CITY UT 84108 0 1 0 0 VP, Human Resources Kevin J. Ontiveros 2005-07-15 EX-24 2 attach_1.htm

Glenn R. Melrose





















 July 15, 2005







Securities and Exchange Commission

Attn: Filing Desk

450 Fifth Street, N.W.

Washington, D.C. 20549



Re: NPS Pharmaceuticals, Inc.

File No. 0-23272



Ladies and Gentlemen,



By means of this letter, I authorize Val R. Antczak, Kevin J. Ontiveros or Morgan R. Brown to sign on my behalf all forms required under Section 16(a) of the Securities Exchange Act of 1934, as amended, relating to transactions involving the stock or derivative securities of NPS Pharmaceuticals, Inc. Accordingly, Messrs. Antczak, Ontiveros and Brown are authorized to sign any Form 3, Form 4, Form 5 or amendment thereto which I am required to file with the same effect as if I had signed them myself.



This authorization shall remain in effect until revoked in writing by me.



Sincerely,







/s/ GLENN R. MELROSE

Glenn R. Melrose



cc: Val R. Antczak, Secretary

NPS Pharmaceuticals, Inc.

383 Colorow Drive

Salt Lake City, Utah 84108

-----END PRIVACY-ENHANCED MESSAGE-----